Company Filing History:
Years Active: 2010-2018
Title: Nellithanath Thankachen Byju: A Pioneer in Anti-Thrombotic Innovations
Introduction
Nellithanath Thankachen Byju is a noteworthy inventor based in Mumbai, India, recognized for her significant contributions to the field of anti-thrombotic compounds. With a portfolio that includes five patents, her work has focused on developing innovative solutions for thrombo-embolism and cardiovascular diseases.
Latest Patents
One of her latest patents involves the development of new anti-thrombotic compounds, specifically the compound (7aS,2'S)-2-oxoclopidogrel and its pharmaceutically acceptable salts. This innovative compound is disclosed for the treatment or prophylaxis of thrombo-embolism and cardiovascular diseases. Additionally, she has invented methods for the treatment or prophylaxis of thrombosis or embolism. This method addresses the limitations of the anti-platelet drug clopidogrel by administering (S)oxo-clopidogrel or its derivatives in their free or pharmaceutically acceptable salt forms to alleviate symptoms of thrombosis or embolism by inhibiting blood platelet aggregation.
Career Highlights
Nellithanath Thankachen Byju is currently employed at Ipca Laboratories Limited, a prominent player in the pharmaceutical industry. Her career at this esteemed company highlights her commitment to advancing medical treatments and enhancing patient care through her inventive work.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues, including Ashok Kumar and Satish Rajanikant Soudagar. These partnerships have enriched her research and development efforts, further driving innovation in the field of cardiovascular medicine.
Conclusion
Nellithanath Thankachen Byju's contributions to anti-thrombotic innovations have positioned her as a vital figure in the medical research community. With her innovative patents and collaborations at Ipca Laboratories Limited, she continues to make strides in improving treatments for thrombo-embolism and cardiovascular diseases, showcasing the impact of dedicated inventors on healthcare advancements.